Atherectomy Devices Market by Product (Directional, Rotational, Laser, Orbital), Application (Peripheral, Cardiovascular, Neurovascular), End User (Hospitals, Surgical Centers, Ascs, Research Laboratories, Academic Institutes) - Global Forecasts To 2022
The atherectomy devices market projected to grow at a CAGR of 6.1%
The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers. The increasing number of research activities in the field of atherectomy and rising healthcare expenditure across emerging markets are also driving the growth of the market. However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.
“The peripheral vascular applications segment is poised to be the fastest-growing during the forecast period.”
On the basis of application, the global atherectomy devices market is segmented into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular atherectomy applications segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment, rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries, and growing patient preference for minimally invasive surgical procedures
“The hospitals & surgical centers segment is expected to have the largest share of the market in 2017.”
In 2017, on the basis of end user, the hospitals and surgical centers segment is expected to account for the largest share of the market. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.
“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC atherectomy devices market can be attributed to the factors such as the presence of increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems.
Breakdown of supply-side primary interviews: by company type, designation, and region:
Research Coverage
This report studies the atherectomy devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the atherectomy devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
The global atherectomy devices market is projected to reach USD 1.45 billion by 2022 from USD 1.08 billion in 2017, at a CAGR of 6.1%. The growth witnessed by atherectomy devices is mainly driven by the growing target patient population, continuous product development & commercialization, favorable medical reimbursements, rising demand for minimally invasive atherectomy procedures, and strengthening distribution channels of major product manufacturers. The increasing number of research activities in the field of atherectomy and rising healthcare expenditure across emerging markets are also driving the growth of the market. However, limited patient awareness related to disease diagnosis (resulting in delayed treatment for peripheral vascular diseases), stringent regulatory framework, dearth of well-trained surgeons to conduct atherectomy procedures, and significant adoption of alternative therapies are the key challenges faced by a majority of the atherectomy device manufacturers across the globe.
“The peripheral vascular applications segment is poised to be the fastest-growing during the forecast period.”
On the basis of application, the global atherectomy devices market is segmented into peripheral vascular, cardiovascular, and neurovascular applications. The peripheral vascular atherectomy applications segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the significant availability of clinical evidence to support therapeutic efficacy of atherectomy in PVD treatment, rising availability of medical reimbursements for peripheral atherectomy procedures across developed countries, and growing patient preference for minimally invasive surgical procedures
“The hospitals & surgical centers segment is expected to have the largest share of the market in 2017.”
In 2017, on the basis of end user, the hospitals and surgical centers segment is expected to account for the largest share of the market. The large share of this segment is attributed to increasing adoption of atherectomy for cardiac & peripheral vascular disease treatment, ongoing technological advancements in the field of minimally invasive or image-guided atherectomy procedures, rising incidence of chronic vascular diseases, and growing availability of healthcare reimbursements across major countries.
“Asia Pacific is expected to register the highest growth rate during the forecast period.”
Geographically, the atherectomy devices market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The highest CAGR for the APAC atherectomy devices market can be attributed to the factors such as the presence of increasing prevalence of target diseases, increasing healthcare expenditure, cost-effective (owing to the increase in localized manufacturing and strengthening of distribution networks of key product manufacturers), and rising awareness among surgeons related to the benefits offered by atherectomy systems.
Breakdown of supply-side primary interviews: by company type, designation, and region:
- By Company Type - Tier 1 – 25%, Tier 2 – 30% and Tier 3 – 45%
- By Designation – C level – 26%, Director level – 30%, Others – 44%
- By Region – North America - 34%, Europe – 26%, APAC – 23%, RoW – 17%
Research Coverage
This report studies the atherectomy devices market based on product, application, and end user. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for the market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to four main regions.
Reasons to Buy the Report:
From an insights perspective, this research report has focused on various levels of analysis—industry trends, market share analysis of top players, and company profiles, which together comprise and discuss basic views on the competitive landscape, emerging and high-growth segments of the atherectomy devices market, and high-growth regions and countries and their respective drivers, restraints, challenges, and opportunities.
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms garner greater market shares. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on product portfolios offered by the major players in the atherectomy devices market. The report analyzes the atherectomy devices market based on product, application, end user, and region
- Product Development: Detailed insights on the research and development activities and product launches in the atherectomy devices market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various atherectomy devices across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the atherectomy devices market
- Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the atherectomy devices market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 OPPORTUNITY INDICATORS
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATHERECTOMY DEVICES MARKET SNAPSHOT
4.2 REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET SIZE, BY PRODUCT (2017 VS. 2022)
4.3 REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET, BY APPLICATION
4.4 APAC: ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION & COUNTRY, 2017
4.5 GEOGRAPHIC ANALYSIS: ATHERECTOMY DEVICES MARKET, BY COUNTRY (2017-2022)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing target patient population
5.2.1.2 Continuous product development and commercialization
5.2.1.3 Favorable medical reimbursement scenario in mature markets
5.2.1.4 Rising demand for minimally invasive surgical procedures
5.2.1.5 Strengthening distribution channels of major product manufacturers
5.2.2 RESTRAINTS
5.2.2.1 Limited patient awareness related to disease diagnosis
5.2.2.2 Stringent regulatory scenario
5.2.2.3 Dearth of skilled and well-trained surgeons
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing number of research activities in the field of atherectomy
5.2.3.2 Increasing healthcare expenditure across emerging markets
5.2.4 CHALLENGES
5.2.4.1 Significant adoption of alternative therapies
5.3 RESEARCH PIPELINE ANALYSIS
5.3.1 DIRECTIONAL ATHERECTOMY
5.3.2 PHOTO-ABLATIVE/LASER ATHERECTOMY
5.3.3 ORBITAL ATHERECTOMY
5.3.4 ROTATIONAL ATHERECTOMY
6 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DIRECTIONAL ATHERECTOMY DEVICES
6.3 ORBITAL ATHERECTOMY DEVICES
6.4 PHOTO-ABLATIVE (LASER) ATHERECTOMY DEVICES
6.5 ROTATIONAL ATHERECTOMY DEVICES
6.6 SUPPORT DEVICES
7 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PERIPHERAL VASCULAR APPLICATIONS
7.3 CARDIOVASCULAR APPLICATIONS
7.4 NEUROVASCULAR APPLICATIONS
8 GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & SURGICAL CENTERS
8.3 AMBULATORY CARE CENTERS
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9 ATHERECTOMY DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2016
10.3 COMPETITIVE SCENARIO AND TRENDS
10.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS
10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 EXPANSIONS
10.3.4 MERGERS & ACQUISITIONS
10.3.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
11.1 INTRODUCTION
11.2 KONINKLIJKE PHILIPS
11.3 MEDTRONIC
11.4 CARDIOVASCULAR SYSTEMS
11.5 BOSTON SCIENTIFIC
11.6 C.R. BARD
11.7 CARDINAL HEALTH
11.8 MINNETRONIX, INC.
11.9 AVINGER
11.10 STRAUB MEDICAL
11.11 BIOMERICS
11.12 BIOTRONIK
11.13 RA MEDICAL SYSTEMS
11.14 TERUMO CORPORATION
11.15 ABBOTT LABORATORIES
11.16 B. BRAUN GROUP
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 MARKET STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 OPPORTUNITY INDICATORS
2.3 MARKET SIZE ESTIMATION
2.3.1 BOTTOM-UP APPROACH
2.3.2 TOP-DOWN APPROACH
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 ATHERECTOMY DEVICES MARKET SNAPSHOT
4.2 REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET SIZE, BY PRODUCT (2017 VS. 2022)
4.3 REGIONAL ANALYSIS: ATHERECTOMY DEVICES MARKET, BY APPLICATION
4.4 APAC: ATHERECTOMY DEVICES MARKET SIZE, BY APPLICATION & COUNTRY, 2017
4.5 GEOGRAPHIC ANALYSIS: ATHERECTOMY DEVICES MARKET, BY COUNTRY (2017-2022)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Growing target patient population
5.2.1.2 Continuous product development and commercialization
5.2.1.3 Favorable medical reimbursement scenario in mature markets
5.2.1.4 Rising demand for minimally invasive surgical procedures
5.2.1.5 Strengthening distribution channels of major product manufacturers
5.2.2 RESTRAINTS
5.2.2.1 Limited patient awareness related to disease diagnosis
5.2.2.2 Stringent regulatory scenario
5.2.2.3 Dearth of skilled and well-trained surgeons
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing number of research activities in the field of atherectomy
5.2.3.2 Increasing healthcare expenditure across emerging markets
5.2.4 CHALLENGES
5.2.4.1 Significant adoption of alternative therapies
5.3 RESEARCH PIPELINE ANALYSIS
5.3.1 DIRECTIONAL ATHERECTOMY
5.3.2 PHOTO-ABLATIVE/LASER ATHERECTOMY
5.3.3 ORBITAL ATHERECTOMY
5.3.4 ROTATIONAL ATHERECTOMY
6 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 DIRECTIONAL ATHERECTOMY DEVICES
6.3 ORBITAL ATHERECTOMY DEVICES
6.4 PHOTO-ABLATIVE (LASER) ATHERECTOMY DEVICES
6.5 ROTATIONAL ATHERECTOMY DEVICES
6.6 SUPPORT DEVICES
7 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PERIPHERAL VASCULAR APPLICATIONS
7.3 CARDIOVASCULAR APPLICATIONS
7.4 NEUROVASCULAR APPLICATIONS
8 GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS & SURGICAL CENTERS
8.3 AMBULATORY CARE CENTERS
8.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9 ATHERECTOMY DEVICES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF ASIA PACIFIC
9.5 REST OF THE WORLD
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 MARKET SHARE ANALYSIS, 2016
10.3 COMPETITIVE SCENARIO AND TRENDS
10.3.1 PRODUCT LAUNCHES AND ENHANCEMENTS
10.3.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.3.3 EXPANSIONS
10.3.4 MERGERS & ACQUISITIONS
10.3.5 OTHER DEVELOPMENTS
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments)*
11.1 INTRODUCTION
11.2 KONINKLIJKE PHILIPS
11.3 MEDTRONIC
11.4 CARDIOVASCULAR SYSTEMS
11.5 BOSTON SCIENTIFIC
11.6 C.R. BARD
11.7 CARDINAL HEALTH
11.8 MINNETRONIX, INC.
11.9 AVINGER
11.10 STRAUB MEDICAL
11.11 BIOMERICS
11.12 BIOTRONIK
11.13 RA MEDICAL SYSTEMS
11.14 TERUMO CORPORATION
11.15 ABBOTT LABORATORIES
11.16 B. BRAUN GROUP
*Details on Overview, Strength of Product Portfolio, Business Strategy Excellence, Products Offering, and Recent Developments might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.4 AVAILABLE CUSTOMIZATIONS
12.5 RELATED REPORTS
12.6 AUTHOR DETAILS
LIST OF TABLES
TABLE 1 IMPACT ANALYSIS: KEY MACROINDICATORS FOR THE ATHERECTOMY DEVICES MARKET, 2016
TABLE 2 MEDICAL REIMBURSEMENTS FOR ATHERECTOMY PROCEDURES
TABLE 3 DIRECTIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 4 PHOTO-ABLATIVE/LASER ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 5 ORBITAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 6 ROTATIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 7 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 8 DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 9 NORTH AMERICA DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 10 EUROPE DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 11 ASIA PACIFIC DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 12 ORBITAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 13 NORTH AMERICA ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 14 EUROPE ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 15 ASIA PACIFIC ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 16 PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 17 NORTH AMERICA PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 18 EUROPE PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 19 ASIA PACIFIC PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 20 ROTATIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 21 NORTH AMERICA ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 22 EUROPE ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 23 ASIA PACIFIC ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 24 ATHERECTOMY DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2015–2022 (USD MILLION)
TABLE 25 NORTH AMERICA SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 26 EUROPE SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 27 ASIA PACIFIC SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 28 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 29 ATHERECTOMY DEVICES MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 30 ATHERECTOMY DEVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 31 ATHERECTOMY DEVICES MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 32 GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 33 ATHERECTOMY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 34 ATHERECTOMY PROCEDURAL COST: OFFICE-BASED LABS VS. AMBULATORY CARE CENTERS, 2016
TABLE 35 ATHERECTOMY DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 36 ATHERECTOMY DEVICES MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
TABLE 37 ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 38 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 39 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 41 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 42 US: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 43 US: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 44 CANADA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 45 CANADA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 46 EUROPE: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 47 EUROPE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 48 EUROPE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 49 EUROPE: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 50 GERMANY: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 51 GERMANY: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 52 FRANCE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 53 FRANCE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 54 UK: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 55 UK: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 56 ROE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 57 ROE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 58 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 59 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 60 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 61 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 62 JAPAN: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 63 JAPAN: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 64 CHINA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 65 CHINA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 66 INDIA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 INDIA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 68 ROAPAC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 69 ROAPAC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 70 ROW: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 71 ROW: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 72 ROW: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 73 MAJOR PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
TABLE 74 MAJOR AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
TABLE 75 MAJOR EXPANSIONS (2014–2017)
TABLE 76 MAJOR MERGERS & ACQUISITIONS (2014–2017)
TABLE 77 MAJOR OTHER DEVELOPMENTS (2014-2017)
TABLE 1 IMPACT ANALYSIS: KEY MACROINDICATORS FOR THE ATHERECTOMY DEVICES MARKET, 2016
TABLE 2 MEDICAL REIMBURSEMENTS FOR ATHERECTOMY PROCEDURES
TABLE 3 DIRECTIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 4 PHOTO-ABLATIVE/LASER ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 5 ORBITAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 6 ROTATIONAL ATHERECTOMY DEVICES: ONGOING CLINICAL TRIALS
TABLE 7 GLOBAL ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 8 DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 9 NORTH AMERICA DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 10 EUROPE DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 11 ASIA PACIFIC DIRECTIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 12 ORBITAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 13 NORTH AMERICA ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 14 EUROPE ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 15 ASIA PACIFIC ORBITAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 16 PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 17 NORTH AMERICA PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 18 EUROPE PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 19 ASIA PACIFIC PHOTO-ABLATIVE ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 20 ROTATIONAL ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 21 NORTH AMERICA ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 22 EUROPE ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 23 ASIA PACIFIC ROTATIONAL ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 24 ATHERECTOMY DEVICES MARKET FOR SUPPORT DEVICES, BY REGION, 2015–2022 (USD MILLION)
TABLE 25 NORTH AMERICA SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 26 EUROPE SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 27 ASIA PACIFIC SUPPORT DEVICES ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 28 GLOBAL ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 29 ATHERECTOMY DEVICES MARKET FOR PERIPHERAL VASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 30 ATHERECTOMY DEVICES MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 31 ATHERECTOMY DEVICES MARKET FOR NEUROVASCULAR APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
TABLE 32 GLOBAL ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 33 ATHERECTOMY DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 34 ATHERECTOMY PROCEDURAL COST: OFFICE-BASED LABS VS. AMBULATORY CARE CENTERS, 2016
TABLE 35 ATHERECTOMY DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY REGION, 2015–2022 (USD MILLION)
TABLE 36 ATHERECTOMY DEVICES MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
TABLE 37 ATHERECTOMY DEVICES MARKET, BY REGION, 2015–2022 (USD MILLION)
TABLE 38 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 39 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 40 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 41 NORTH AMERICA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 42 US: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 43 US: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 44 CANADA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 45 CANADA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 46 EUROPE: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 47 EUROPE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 48 EUROPE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 49 EUROPE: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 50 GERMANY: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 51 GERMANY: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 52 FRANCE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 53 FRANCE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 54 UK: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 55 UK: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 56 ROE: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 57 ROE: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 58 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
TABLE 59 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 60 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 61 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 62 JAPAN: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 63 JAPAN: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 64 CHINA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 65 CHINA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 66 INDIA: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 67 INDIA: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 68 ROAPAC: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 69 ROAPAC: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 70 ROW: ATHERECTOMY DEVICES MARKET, BY PRODUCT, 2015–2022 (USD MILLION)
TABLE 71 ROW: ATHERECTOMY DEVICES MARKET, BY END USER, 2015–2022 (USD MILLION)
TABLE 72 ROW: ATHERECTOMY DEVICES MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
TABLE 73 MAJOR PRODUCT LAUNCHES AND ENHANCEMENTS (2014–2017)
TABLE 74 MAJOR AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2014–2017)
TABLE 75 MAJOR EXPANSIONS (2014–2017)
TABLE 76 MAJOR MERGERS & ACQUISITIONS (2014–2017)
TABLE 77 MAJOR OTHER DEVELOPMENTS (2014-2017)
LIST OF FIGURES
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: ATHERECTOMY DEVICES MARKET
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION
FIGURE 6 DIRECTIONAL ATHERECTOMY IS ESTIMATED TO BE HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 7 DIRECTIONAL ATHERECTOMY IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES PRODUCT MARKET DURING THE FORECAST PERIOD
FIGURE 8 HOSPITALS & SURGICAL CENTERS IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES END USER MARKET DURING THE FORECAST PERIOD
FIGURE 9 NORTH AMERICA TO DOMINATE THE GLOBAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 10 GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR ATHERECTOMY DEVICES DURING THE FORECAST PERIOD
FIGURE 11 DIRECTIONAL ATHERECTOMY DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE ATHERECTOMY DEVICES MARKET ACROSS ALL REGIONS IN 2022
FIGURE 12 NORTH AMERICA DOMINATED THE ATHERECTOMY DEVICES MARKET FOR ALL APPLICATION SEGMENTS IN 2017
FIGURE 13 PERIPHERAL VASCULAR APPLICATION WILL DOMINATE THE ASIA PACIFIC ATHERECTOMY DEVICES APPLICATION MARKET IN 2017
FIGURE 14 CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL ATHERECTOMY DEVICES MARKET
FIGURE 15 ATHERECTOMY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 PROPORTION OF GERIATRIC POPULATION: BY COUNTRY (2012 VS. 2020)
FIGURE 17 ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF SEPTEMBER 2016)
FIGURE 18 GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2015)
FIGURE 19 ANGIOPLASTY PROCEDURE COSTS ACROSS MAJOR COUNTRIES, 2016
FIGURE 20 INCIDENCE OF ANGIOPLASTY PROCEDURES ACROSS MAJOR EUROPEAN COUNTRIES (2009 VS. 2014)
FIGURE 21 DIRECTIONAL ATHERECTOMY DEVICES SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 22 NORTH AMERICA TO HOLD LARGEST SHARE OF THE DIRECTIONAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 23 PERIPHERAL VASCULAR APPLICATIONS SEGMENT TO DOMINATE THE ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 24 NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
FIGURE 25 HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE HOSPITALS & SURGICAL CENTERS MARKET DURING THE FORECAST PERIOD
FIGURE 27 NORTH AMERICA: ATHERECTOMY DEVICES MARKET SNAPSHOT (2017-2022)
FIGURE 28 EUROPE: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 30 ROW: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 31 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ATHERECTOMY DEVICES MARKET, 2014–2017
FIGURE 32 GLOBAL ATHERECTOMY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 33 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
FIGURE 34 KONINKLIJKE PHILIPS: SWOT ANALYSIS
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT
FIGURE 36 MEDTRONIC: SWOT ANALYSIS
FIGURE 37 CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
FIGURE 38 CARDIOVASCULAR SYSTEMS: SWOT ANALYSIS
FIGURE 39 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 40 BOSTON SCIENTIFIC: SWOT ANALYSIS
FIGURE 41 C.R.BARD: COMPANY SNAPSHOT
FIGURE 42 C.R.BARD: SWOT ANALYSIS
FIGURE 43 CARDINAL HEALTH: COMPANY SNAPSHOT
FIGURE 44 AVINGER: COMPANY SNAPSHOT
FIGURE 45 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 47 B. BRAUN GROUP: COMPANY SNAPSHOT
FIGURE 1 RESEARCH DESIGN
FIGURE 2 BREAKDOWN OF PRIMARIES: ATHERECTOMY DEVICES MARKET
FIGURE 3 BOTTOM-UP APPROACH
FIGURE 4 TOP-DOWN APPROACH
FIGURE 5 DATA TRIANGULATION
FIGURE 6 DIRECTIONAL ATHERECTOMY IS ESTIMATED TO BE HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 7 DIRECTIONAL ATHERECTOMY IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES PRODUCT MARKET DURING THE FORECAST PERIOD
FIGURE 8 HOSPITALS & SURGICAL CENTERS IS ESTIMATED TO HOLD THE LARGEST SHARE IN ATHERECTOMY DEVICES END USER MARKET DURING THE FORECAST PERIOD
FIGURE 9 NORTH AMERICA TO DOMINATE THE GLOBAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 10 GROWING TARGET PATIENT POPULATION TO PROPEL THE DEMAND FOR ATHERECTOMY DEVICES DURING THE FORECAST PERIOD
FIGURE 11 DIRECTIONAL ATHERECTOMY DEVICES SEGMENT WILL CONTINUE TO DOMINATE THE ATHERECTOMY DEVICES MARKET ACROSS ALL REGIONS IN 2022
FIGURE 12 NORTH AMERICA DOMINATED THE ATHERECTOMY DEVICES MARKET FOR ALL APPLICATION SEGMENTS IN 2017
FIGURE 13 PERIPHERAL VASCULAR APPLICATION WILL DOMINATE THE ASIA PACIFIC ATHERECTOMY DEVICES APPLICATION MARKET IN 2017
FIGURE 14 CHINA & INDIA ESTIMATED TO BE THE FASTEST-GROWING COUNTRIES IN THE GLOBAL ATHERECTOMY DEVICES MARKET
FIGURE 15 ATHERECTOMY DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16 PROPORTION OF GERIATRIC POPULATION: BY COUNTRY (2012 VS. 2020)
FIGURE 17 ONGOING CLINICAL TRIALS ACROSS THE GLOBE (AS OF SEPTEMBER 2016)
FIGURE 18 GOVERNMENT HEALTHCARE EXPENDITURE: DEVELOPED VS. DEVELOPING COUNTRIES (2010 VS. 2015)
FIGURE 19 ANGIOPLASTY PROCEDURE COSTS ACROSS MAJOR COUNTRIES, 2016
FIGURE 20 INCIDENCE OF ANGIOPLASTY PROCEDURES ACROSS MAJOR EUROPEAN COUNTRIES (2009 VS. 2014)
FIGURE 21 DIRECTIONAL ATHERECTOMY DEVICES SEGMENT TO WITNESS HIGHEST MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 22 NORTH AMERICA TO HOLD LARGEST SHARE OF THE DIRECTIONAL ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 23 PERIPHERAL VASCULAR APPLICATIONS SEGMENT TO DOMINATE THE ATHERECTOMY DEVICES MARKET DURING THE FORECAST PERIOD
FIGURE 24 NORTH AMERICA TO HOLD LARGEST SHARE OF THE PERIPHERAL VASCULAR APPLICATION MARKET DURING THE FORECAST PERIOD
FIGURE 25 HOSPITALS & SURGICAL CENTERS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
FIGURE 26 NORTH AMERICA TO HOLD LARGEST SHARE OF THE HOSPITALS & SURGICAL CENTERS MARKET DURING THE FORECAST PERIOD
FIGURE 27 NORTH AMERICA: ATHERECTOMY DEVICES MARKET SNAPSHOT (2017-2022)
FIGURE 28 EUROPE: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 29 ASIA PACIFIC: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 30 ROW: ATHERECTOMY DEVICES MARKET SNAPSHOT
FIGURE 31 KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE ATHERECTOMY DEVICES MARKET, 2014–2017
FIGURE 32 GLOBAL ATHERECTOMY DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
FIGURE 33 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
FIGURE 34 KONINKLIJKE PHILIPS: SWOT ANALYSIS
FIGURE 35 MEDTRONIC: COMPANY SNAPSHOT
FIGURE 36 MEDTRONIC: SWOT ANALYSIS
FIGURE 37 CARDIOVASCULAR SYSTEMS: COMPANY SNAPSHOT
FIGURE 38 CARDIOVASCULAR SYSTEMS: SWOT ANALYSIS
FIGURE 39 BOSTON SCIENTIFIC: COMPANY SNAPSHOT
FIGURE 40 BOSTON SCIENTIFIC: SWOT ANALYSIS
FIGURE 41 C.R.BARD: COMPANY SNAPSHOT
FIGURE 42 C.R.BARD: SWOT ANALYSIS
FIGURE 43 CARDINAL HEALTH: COMPANY SNAPSHOT
FIGURE 44 AVINGER: COMPANY SNAPSHOT
FIGURE 45 TERUMO CORPORATION: COMPANY SNAPSHOT
FIGURE 46 ABBOTT LABORATORIES: COMPANY SNAPSHOT
FIGURE 47 B. BRAUN GROUP: COMPANY SNAPSHOT
